Vol 85, No 5 (2014)
ARTICLES
Tocolysis in preterm labour – current recommendations
Mirosław Wielgoś, Dorota A. Bomba-Opoń
DOI: 10.17772/gp/1732
·
Ginekol Pol 2014;85(5).
Vol 85, No 5 (2014)
ARTICLES
Abstract
Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity. Currently, tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit. Only oxytocin receptor antagonist – atosiban and short-acting beta-agonists – fenoterol are licensed to reduce preterm uterine activity. Owing to its safety and efficacy, atosiban should be the first-choice tocolytic, especially in women with other diseases or multiple gestations.Tokoliza w porodzie przedwczesnym – aktualne wytyczne
Abstract
Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity. Currently, tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit. Only oxytocin receptor antagonist – atosiban and short-acting beta-agonists – fenoterol are licensed to reduce preterm uterine activity. Owing to its safety and efficacy, atosiban should be the first-choice tocolytic, especially in women with other diseases or multiple gestations.Tokoliza w porodzie przedwczesnym – aktualne wytyczne
Title
Tocolysis in preterm labour – current recommendations
Journal
Ginekologia Polska
Issue
Vol 85, No 5 (2014)
Page views
1200
Article views/downloads
21633
DOI
10.17772/gp/1732
Bibliographic record
Ginekol Pol 2014;85(5).
Authors
Mirosław Wielgoś
Dorota A. Bomba-Opoń